Financials in USD. Standardized financial statements.
A compact view of how Vitrolife AB (publ) turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $3.23B | $3.61B | $3.51B | $3.23B | $1.68B | $1.25B | $1.48B | $1.15B | $1.05B | $856.11M |
| Revenue Growth? | -10.4% | +2.8% | +8.6% | +92.4% | +34.9% | -15.8% | +28.6% | +10.0% | +22.2% | 0.0% |
| Cost of Revenue? | $1.44B | $1.47B | $1.53B | $1.45B | $634.71M | $477.90M | $541.48M | $390.22M | $364.51M | $294.81M |
| Gross Profit? | $2.00B | $2.14B | $1.98B | $1.78B | $1.05B | $767.67M | $938.65M | $761.12M | $681.71M | $561.30M |
| Gross Margin? | +61.8% | +59.3% | +56.3% | +55.0% | +62.2% | +61.6% | +63.4% | +66.1% | +65.2% | +65.6% |
| Operating Expenses? | $1.42B | $1.36B | $5.57B | $1.15B | $619.68M | $391.86M | $450.47M | $372.05M | $338.37M | $313.09M |
| Operating Income? | $579.03M | $783.00M | -$3.59B | $654.00M | $435.38M | $370.01M | $487.95M | $393.92M | $340.86M | $248.84M |
| EBITDA? | $980.41M | $1.16B | -$3.19B | $977.00M | $579.00M | $438.64M | $594.39M | $483.75M | $408.31M | $304.04M |
| Income Before Tax | -$4.59B | $674.00M | -$3.71B | $537.00M | $459.97M | $366.19M | $492.69M | $398.58M | $340.92M | $248.93M |
| Income Tax Expense | $119.38M | $160.00M | $139.00M | $143.00M | $116.41M | $78.33M | $108.86M | $87.89M | $76.31M | $57.72M |
| Net Income? | -$4.71B | $513.00M | -$3.85B | $394.00M | $341.00M | $286.85M | $382.79M | $309.70M | $263.64M | $190.37M |
| EPS? | $-34.79 | $3.79 | $-28.44 | $2.91 | $2.97 | $2.64 | $3.53 | $2.85 | $2.43 | $1.75 |
| Diluted EPS? | $-34.79 | $3.78 | $-28.44 | $2.91 | $2.97 | $2.64 | $3.53 | $2.85 | $2.43 | $1.75 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality